Dyspepsia

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Dyspepsia = Grade 1-2 Maintain dose and treat with histamine (H 2) blockers or equivalent. Decrease by one dose level if symptoms persist. Dyspepsia ≥ Grade 3 Interrupt dose until symptoms are controlled. Add H 2 blocker or equivalent and resume at …

  Dyspepsia

Osteoporosis Screening, Diagnosis, and Treatment Guideline ...

Dyspepsia ; Nausea . Flatulence . Gastritis . 12.6% • Take the medication in the morning at least 30 minutes before food with a full glass (8 oz.) of plain water. • Do not lie down for at least 30 minutes after taking the medication. • Zoledronic acid (IV bisphosphonate) is an

  Osteoporosis, Dyspepsia

HIGHLIGHTS OF PRESCRIBING INFORMATION These …

In the clinical studies, gastrointestinal events of nausea, diarrhea, dyspepsia, vomiting, gastro-esophageal reflux disease, and abdominal pain were more frequently reported by patients in the ESBRIET treatment groups than in those taking placebo. Dosage reduction or

  Information, Prescribing, Prescribing information, Dyspepsia

SARCOIDOSIS TREATMENT GUIDELINES

diarrhea, dyspepsia, headache, rash, pruritus, pharyngitis and sinusitis, and sore throat. Local injection site reactions have been reported. Adalimumab also increases the risk of infection and certain types of cancer,autoimmune disease and demyelinating disease. Adalimumab should be consid-ered for patients who have been treated successfully with

  Dyspepsia

DRUG NAME: Bortezomib - BC Cancer

•Hepatitis B (HBV) reactivation: All lymphoma and myeloma patients should be tested for both HBsAg and HBcAb. If either test is positive, such patients should be treated with lamivudine 100 mg/day orally, for the entire